Login

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva - Jan Edöcs, CEO, Doxa 00:00:00

Share On Facebook Share On Twitter

Exclusive Interview with Doxa CEO Jan Edöcs at Geneva

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Pam Silver | Addressing Global Issues Through Biology
00:10:00
provide social and financial resources to Black owned companies|Barry Givens,Managing Partner,Collab Capital
00:10:00
Antler is a global pre-seed VC firm now in over 20 cities internationally|Amy Zaghloul,Director, Canada,Antler
00:10:00
Mike Speetzen, Polaris CEO, discusses investor day, earnings, and the state of high-ticket consumers on 'Closing Bell: Overtime'.|Jae-Ho Kim is Director & Head-Management Support at Polaris Office Corp.
00:00:00
Admedus Ltd proud to unveil its valves publicly for the first time in London - Wayne Paterson, CEO, Admedus Ltd
00:10:00
Wiser Welcomes Matthews Barnett, CFP, ChFC, CLU
00:10:00
How Tony Fernandes Turned a 30-Cent Airline Purchase into a Multi-Billion Dollar Empire | Tony Fernandes, CEO, AirAsia Bhd.
00:10:00
Rahul Sharma's Budget 2024 Analysis: Market Trends, Nifty Outlook, and Sector Performances
00:10:00
Ian Stentiford, Managing Director of Evoqua Water Technologies UK and segment leader for electro-chlorination, finds invaluable support and dynamic learning through Vistage, enhancing his leadership and personal clarity.
00:10:00
Emerging Gold Miner Cora Gold Aims for Major Discoveries in Mali
00:10:00
"7th WAM Investor Day emphasized transitioning towards a profitable and sustainable economy, led by Jochen Wermuth of Wermuth Asset Management."
00:10:00
A smart inside take on the day’s politics|Jonathan Capehart,Associate Editor, The Washington Post

© 2017 - Neuhu+